“alkermes” Archives

in
Entry Author Date Location
Alkermes Eyes FDA Nod After Retooled Study Yields Desired Results 10/20/16 Boston
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders 10/20/16 San Francisco
Intra-Cellular Shares Sink As Schizophrenia Drug Flunks Final Test 09/28/16 New York
Caveats But No “Quicksand” In Sage’s Positive Postpartum Trial Data 07/12/16 Boston
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Minerva’s Shares Soar on Early Data for Schizophrenia Drug 05/26/16 Boston
East Coast Biotech Roundup: Alkermes, Zafgen, Snowmaggedon & More 01/22/16 Boston
Depression Trials Fail, Alkermes Sees Silver Lining. Investors Don’t. 01/21/16 Boston
Amid Neuroscience Renaissance, BlackThorn Quietly Builds a Business 12/23/15 San Francisco
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
With Early Data, Alkermes Plots Quick Jump to Pivotal Study For MS Drug 02/09/15 Boston
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Alkermes Spinoff Civitas, Poised for IPO, Sells to Acorda for $525M 09/24/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks 07/01/14 Boston
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Alkermes CEO Richard Pops on Building Big, Playing Well with Pharma 04/18/14 Boston
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug 04/08/14 Boston
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
East Coast Biotech Roundup: VentriNova, RainDance, Biogen, & More 03/07/14 Boston
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
The Big Guys Have Lost Their Iron Grip, and It’s All Good 01/20/14 National
Page 1 of 7 next page »